Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Jounce Therapeutics, Inc. (JNCE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.17+0.16 (+2.66%)
At close: 04:00PM EST
6.08 -0.09 (-1.46%)
After hours: 05:57PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/23/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 314.84
52 Week Low 35.03
50-Day Moving Average 37.67
200-Day Moving Average 37.46

Share Statistics

Avg Vol (3 month) 3414.05k
Avg Vol (10 day) 3337.2k
Shares Outstanding 551.24M
Implied Shares Outstanding 6N/A
Float 826.76M
% Held by Insiders 118.26%
% Held by Institutions 179.01%
Shares Short (Dec 14, 2021) 41.04M
Short Ratio (Dec 14, 2021) 42.47
Short % of Float (Dec 14, 2021) 42.88%
Short % of Shares Outstanding (Dec 14, 2021) 42.03%
Shares Short (prior month Nov 14, 2021) 4887.51k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin -28.20%
Operating Margin (ttm)-28.41%

Management Effectiveness

Return on Assets (ttm)-7.61%
Return on Equity (ttm)-14.12%

Income Statement

Revenue (ttm)89.25M
Revenue Per Share (ttm)1.90
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)25.35M
EBITDA -22.37M
Net Income Avi to Common (ttm)-25.17M
Diluted EPS (ttm)-0.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)219.6M
Total Cash Per Share (mrq)4.28
Total Debt (mrq)14.5M
Total Debt/Equity (mrq)5.77
Current Ratio (mrq)12.67
Book Value Per Share (mrq)4.91

Cash Flow Statement

Operating Cash Flow (ttm)-15.95M
Levered Free Cash Flow (ttm)-7.43M
Advertisement
Advertisement